InsidersTradesSigma
Follow the 명인제약 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 명인제약 has logged 1 reports. Market capitalisation: €616.1bn. The latest transaction was reported on 6 April 2026 (Mixed). Among the most active insiders: 이동철. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Myungjin Pharmaceutical es una empresa farmacéutica surcoreana centrada en el desarrollo y la fabricación de medicamentos. Cotiza en el mercado XKRX.